Hormone replacement therapy: Findings of women's health initiative trial need not alarm users

BMJ

Volumn 325, Issue 7356, 2002, Pages 113-114

  Stevenson, John C ^a   Whitehead, Malcolm I ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; SEX HORMONE;

BREAST CANCER; CANCER RISK; COLORECTAL CANCER; DRUG INDICATION; EDITORIAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; OSTEOPOROSIS; OUTCOMES RESEARCH; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SURVIVAL;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; RISK FACTORS;

EID: 0037143028     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.325.7356.113     Document Type: Editorial

References (7)

1. Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321–333.
2. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative re-analysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997; 350: 1047–1059.
3. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605–613.
4. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000; 343: 522–529.
5. Schulman SP, Thiemann DR, Ouyang P, Chandra NC, Schulman DS, Reis SE, et al. Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina. J Am Coll Cardiol 2002; 39: 231–237.
6. Stevenson JC. Cardiovascular effects of estrogens. J Steroid Biochem Mol Biol 2000; 74: 387–393.
7. Medicines Control Agency, Committee on Safety of Medicines. New product information for hormone replacement therapy. Curr Problems Pharmacovigilance 2002; 28: 1–2.